Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES SJ IN SALE OF LINKON
Mandate

VINGE ADVISES SJ IN SALE OF LINKON

December 31, 2014

Vinge assists SJ AB in connection with its sale of 75% of the shares in Linkon AB to SilverRail. SJ retains a 25% interest in the company. Linkon develops and provides advanced ticket- and payment systems for the travel industry, with a focus on rail transportation, and has under SJ’s ownership developed on the Nordic market. SilverRail is a growth oriented company with extensive experience within the railway sector, with presence on the European market e.g. in the UK, Germany and Italy.

Vinge’s team consisted of among others responsible partner Eva Fredriksson and project manager Peter Sundgren as well as associates Louise Berkelius, Charlotta Järnstedt, Filip Brosset, partner Marcus Glader and associate Emil Fahlén-Godö.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026